NEW YORK (TheStreet) -- Some financial people do not really look at all the good things drug companies do. Instead, they focus on the creative destruction that happens when new replaces the old.
Think of all the popular brand names of the last decade: Rogaine, Plavix, Cymbalta, Oxycontin, Celebrex. It's a long list of exclusive money-making home runs now generic also-rans starring with a different label at a pharmacy shelf near you.
While lots of analysts like to pay attention to the pipelines full of miracle drugs of tomorrow, some companies do quite well with the miracle drugs of yesterday -- the generics.
Data from Best Stocks Now App One pharmaceutical that has performed and continues to perform quite well is Actavis. It has been a Gunderson Best Stock Now for quite some time and continues to be.
Data from Best Stocks Now App Headquartered in New Jersey, ACT is a $31 billion large-cap company that develops, manufactures and distributes generic and branded drugs for hypertension, elevated cholesterol, contraception and pain. It is currently working on a generic NuvaRing, a contraceptive.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts